Last reviewed · How we verify
Nanocrystalline megestrol acetate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Nanocrystalline megestrol acetate (Nanocrystalline megestrol acetate) — Guangzhou Institute of Respiratory Disease.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nanocrystalline megestrol acetate TARGET | Nanocrystalline megestrol acetate | Guangzhou Institute of Respiratory Disease | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nanocrystalline megestrol acetate CI watch — RSS
- Nanocrystalline megestrol acetate CI watch — Atom
- Nanocrystalline megestrol acetate CI watch — JSON
- Nanocrystalline megestrol acetate alone — RSS
Cite this brief
Drug Landscape (2026). Nanocrystalline megestrol acetate — Competitive Intelligence Brief. https://druglandscape.com/ci/nanocrystalline-megestrol-acetate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab